John M. Maris

Person

Moorestown, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Glypican 2 as a cancer marker and therapeutic target
- Patent number 11,814,440
- Issue date Nov 14, 2023
- The Children's Hospital of Philadelphia
- John M. Maris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates for targeting CD56-positive tumors
- Patent number 10,548,987
- Issue date Feb 4, 2020
- The United States of America, as represented by the Secretary, Department of...
- Dimiter S. Dimitrov
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for identifying, diagnosing, and treating...
- Patent number 10,017,822
- Issue date Jul 10, 2018
- The Children's Hospital of Philadelphia
- John M. Maris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
GLYPICAN 2 AS A CANCER MARKER AND THERAPEUTIC TARGET
- Publication number 20240084034
- Publication date Mar 14, 2024
- The Children's Hospital of Philadelphia
- John M. MARIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SARS-COV-2 VACCINES FOR POPULATION-SCALE IMMUNITY
- Publication number 20230218741
- Publication date Jul 13, 2023
- The Children's Hospital of Philadelphia
- John M. MARIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2
- Publication number 20220315665
- Publication date Oct 6, 2022
- The Board of Trustees of the Leland Stanford Junior University
- Sabine HEITZENEDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS CONTAINING GLYPICAN 2 BINDING DOMAINS
- Publication number 20220257653
- Publication date Aug 18, 2022
- The Children's Hospital of Philadelphia
- Kristopher BOSSE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR USE OF TUMOR SELF-ANTIGENS IN ADOPTIVE...
- Publication number 20210213058
- Publication date Jul 15, 2021
- The Children's Hospital of Philadelphia
- JOHN M MARIS
- G01 - MEASURING TESTING
Information Patent Application
GLYPICAN 2 AS A CANCER MARKER AND THERAPEUTIC TARGET
- Publication number 20180318444
- Publication date Nov 8, 2018
- The Children's Hospital of Philadelphia
- John M. MARIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS
- Publication number 20180214568
- Publication date Aug 2, 2018
- The USA, as represented by the Secretary, Department of Health and Human Serv...
- Dimiter S. Dimitrov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES
- Publication number 20170239294
- Publication date Aug 24, 2017
- The Trustees of the University of Pennsylvania
- Andrei Thomas-Tikhonenko
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARID1B AND NEUROBLASTOMA
- Publication number 20150252415
- Publication date Sep 10, 2015
- The Children's Hospital of Philadelphia
- Bert Vogelstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and Compositions for Identifying, Diagnosing, and Treating...
- Publication number 20150118243
- Publication date Apr 30, 2015
- The Children's Hospital of Philadelphia
- John M. Maris
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods and Compositions for Identifying, Diagnosing, and Treating...
- Publication number 20110020365
- Publication date Jan 27, 2011
- John M. Maris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for detection of genetic alterations associated with cancer
- Publication number 20040132047
- Publication date Jul 8, 2004
- Paolo Fortina
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

John M. Maris

Person

Patents Grantslast 30 patents

Glypican 2 as a cancer marker and therapeutic target

Antibody-drug conjugates for targeting CD56-positive tumors

Methods and compositions for identifying, diagnosing, and treating...

Patents Applicationslast 30 patents

GLYPICAN 2 AS A CANCER MARKER AND THERAPEUTIC TARGET

SARS-COV-2 VACCINES FOR POPULATION-SCALE IMMUNITY

CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2

CHIMERIC ANTIGEN RECEPTORS CONTAINING GLYPICAN 2 BINDING DOMAINS

METHODS AND COMPOSITIONS FOR USE OF TUMOR SELF-ANTIGENS IN ADOPTIVE...

GLYPICAN 2 AS A CANCER MARKER AND THERAPEUTIC TARGET

ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS

COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES

ARID1B AND NEUROBLASTOMA

Methods and Compositions for Identifying, Diagnosing, and Treating...

Methods and Compositions for Identifying, Diagnosing, and Treating...

Methods for detection of genetic alterations associated with cancer